DIAGNOSTIC ACCURACY OF CA-125 LEVELS WITH ULTRASONOGRAPHY TO PREDICT OVARIAN CÁNCER

Abstract

To establish the diagnostic accuracy of CA-125 levels with ultrasonography to predict ovarian cancer in patients of the Teodoro Maldonado Carbo Specialty Hospital during 2015-2016. Methodology: An observational, quantitative, analytical, retrospective and cross-sectional study, which included 322
patients from the Teodoro Maldonado Carbo specialty hospital during the period from January 1, 2015 to December 31, 2016. Descriptive statistics were used. inferential, in addition to the statistical software SPSS version 21 for statistical processing. Results: The average age was 53.77 years with (SD + - 15.2),
the average age group of adults (41-60 years) was the highest proportion with 46.3%. The most common ultrasonographic findings were: adnexal mass (48.1%), mass> 4 cm (22.2%), anechoic image (18%) and liquid content image (15.5%). It is concluded that the determination of CA125 is a good test to predict
ovarian cancer, due to its specificity of 55.75% and sensitivity of 91.38%, while ultrasonography findings due to its low sensitivity and specificity are not considered an adequate test to predict ovarian cancer.

Keywords: Cancer ovary, Ca-125, ultrasonography.

References

[1]A. L. Wilbaux, "Dynamic modeling in ovarian cancer: an original approach linking early changes in modeled longitudinal CA-125 kinetics and survival to help
de- cisions in early drug development", Gynecol Oncol, Vol. 133, no. 38, pp. 460- 466, Feb, 2018.

[2]S. Garg, "Evaluation of IOTA simple ultrasound rules to distinguish benign and malignant ovarian tumours", J Clin Diagn Res, Vol. 11, no. 43, pp. TC06–9, 2017.

[3]H. C. Marret, "Sonographic diagnosis of presumed benign ovarian tumors", J Gynecol Obstet Biol Reprod (Paris)", Vol. 42, no. 8, pp.730-43, Dec, 2015.

[4]B. Reid, "Epidemiology of ovarian cancer: a review", Cancer Biol Med, Vol. 14, no. 1, pp. 9–32. Feb, 2017.

[5]T. Johari-Ahar, "An ultra-sensitive impedimetric immunosensor for detection of the serum oncomarker CA-125 in ovarian cancer patients", Nanoscale. Vol. 7, no. 8, pp. 3768-79. Feb, 2015.

[6]U. Memar, "The Prognostic Role of Tumor Marker CA-125 in B-Cell non-Hodgkin's Lymphoma", Iran J Cancer Prev, Vol. 8, no. 1, pp. 42-6, Jan-Feb, 2015.

[7]D. Peng, "A study of ovarian cancer biomarker amplification using ultrasound for early stage detection", Ultrasonics. Vol. 54, no. 2, pp. 451-4, Feb, 2014.

[8]I. O. Sayasneh, "The characteristic ultrasound features of specific types of ovarian pathology (review)", Int J Oncol, Vol. 46, no. 2, pp. 445-58, 2014.

[9]H. Marret, "Sonographic diagnosis of presumed benign ovarian tumors", J Gynecol Obstet Biol Reprod (Paris), Vol. 42, no. 8, pp. 730-43, Dec, 2015.

[10]H. L. Ionescu, "Correlation of ultrasound features and the Risk of Ovarian Malignancy Algorithm score for different histopathological subtypes of benign adnexal masses" Medicine, Vol. 97, no. 31, pp. e11762. Aug, 2018.